Aurobindo to Acquire Remaining 49% in GLS Pharma for ₹22.5 Crore
Aurobindo Pharma has announced plans to acquire the remaining 49% stake in GLS Pharma for ₹22.5 crore, making GLS Pharma a wholly-owned subsidiary. The deal involves purchasing the shares at ₹381.12 each, with the transaction expected to be completed by December 2024. Aurobindo had first bought 51 per cent of GLS Pharma in June 2022 […]
Aurobindo to Acquire Remaining 49% in GLS Pharma for ₹22.5 Crore Read More »









